Fabio Martinelli

Login • Instagram Welcome back to Instagram. Sign in to check out what your friends, family & interests have been capturing & sharing around the world.

#Cervical cancer #prevention week
#HPV #vaccine #paptest

www.instagram.com/reel/DDkaBhG...

19.01.2025 08:03 — 👍 2    🔁 1    💬 0    📌 0

#Tumori #Ginecologici
Ecco il mio intervento a TG4 Medicina

mediasetinfinity.mediaset.it/video/tg4/tu...

15.12.2024 21:33 — 👍 0    🔁 0    💬 0    📌 0

📌 Association Between Risk-Reducing Surgeries and Survival in Young BRCA Carriers with Breast Cancer: Results from an International Cohort Study presented by prof Matteo Lambertini 👏🏻
#SABCS24 #GeneralSession1 #day2 @oncoalert.bsky.social #OncoAlertAF

11.12.2024 17:22 — 👍 7    🔁 4    💬 1    📌 0

📌 Educational Session 1: Mind the Gap - Breast Cancer in the Young
“Ovarian Suppression: Who, When, Why, and for How Long” great presentation by Prudence Francis 👏🏻
#SABCS24 #day1 @oncoalert.bsky.social #OncoAlertAF

10.12.2024 23:16 — 👍 6    🔁 3    💬 0    📌 0

Managing Germline Mutations in Hereditary Breast Cancer Risk Hereditary breast cancers are caused by germline mutations, which are genetic mutations inherited at conception and so called because they originate in germ cells, those that develop into reproductive...

Managing Germline Mutations in #BreastCancer Risk: Results from inherited mutations are primarily in #BRCA genes. Additional genes like #TP53, #PTEN, #PALB2, #CHEK2, & #ATM also contribute to #hereditarycancer risk @AJMC_Journal

#genetics #bcsm #hereditarycancer

www.ajmc.com/view/managin...

23.11.2024 16:10 — 👍 5    🔁 1    💬 0    📌 0

"Vaginal Estrogen Use in Breast Cancer Survivors: A Systematic Review and Meta-Analysis of Recurrence and Mortality Risks" - American Journal of Obstetrics & Gynecology To assess the risk of breast cancer recurrence, breast cancer-specific mortality, and overall mortality for breast cancer survivors receiving vaginal estrogen therapy for genitourinary syndrome of men...

Vaginal Estrogen Use in #breastcancer Survivors: A Systematic Review and Meta-Analysis of Recurrence and Mortality Risks @AJOG_thegray ajog.org/article/S0002-…

No ⬆️ recurrences
No ⬆️ mortality
‼️Better #QoL‼️

@oncoalert.bsky.social @weoncologists.bsky.social

22.11.2024 20:19 — 👍 11    🔁 7    💬 1    📌 0

Hyperthermic Intraperitoneal Chemotherapy in Platinum-Sensitive Recurrent Ovarian Cancer: A Randomized Trial on Survival Evaluation (HORSE; MITO-18) | Journal of Clinical Oncology PURPOSETo investigate whether the addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to secondary cytoreductive surgery (SCS) without neoadjuvant chemotherapy has a benefit on progression-f...

HIPEC in Platinum-Sensitive Recurrent #ovariancancer: RCT (HORSE; MITO-18) | @JCO_ASCO ascopubs.org/doi/10.1200/...

167 pts
median follow up 83mo
No NACT before SCS
mPFS:
- 23mo surgery alone
- 25mo surgery + HIPEC
No PFS benefit of adding HIPEC
@oncoalert.bsky.social @weoncologists.bsky.social

22.11.2024 19:25 — 👍 4    🔁 3    💬 0    📌 0

We Are @oncoalert.bsky.social !!

19.11.2024 19:57 — 👍 7    🔁 4    💬 0    📌 0

OncoAlert along with our partners at ESSO, ESGO, MASCC & SIOG Proudly Announce 1/3 of our faculty, more soon@

Register HERE
https://buff.ly/3CChgre

@elisabettabonzano.bsky.social
@elisaagostinetto.bsky.social
@realbowtiedoc.bsky.social
@erikahamilton9.bsky.social
@agerikssonmd.bsky.social

19.11.2024 16:11 — 👍 19    🔁 10    💬 0    📌 3